Stock Quotes in this Article: ARRY, CLDX, CUR, FOLD

WINDERMERE, Fla. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

>>5 Toxic Stocks to Dump Before 2013

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

>>5 Dividend Stocks Itching to Pay You More

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside today.

Amicus Therapeutics (FOLD)

This is a clinical-stage biopharmaceutical company is focused on the discovery, development and commercialization of a new class of orally-administered, small molecule drugs, for the treatment of a range of human genetic diseases. This stock is trading up 10.5% to $5.43 in recent trading.

Today's Range: $4.93-$5.45

52-Week Range: $2.33-$7.29

Volume: 793,000

Three-Month Average Volume: 421,787

From a technical perspective, FOLD is ripping higher here back above both its 50-day at $5.25 and its 200-day at $5.28 with heavy upside volume. This move is quickly pushing FOLD within range of triggering a near-term breakout trade. That trade will hit once FOLD manages to take out some near-term overhead resistance at $5.60 with high volume.

Traders should now look for long-biased trades in FOLD as long as it's trending above its 50-day at $5.25, and then once it sustains a move or close above $5.60 with volume that hits near or above 421,787 shares. If that breakout triggers soon, then FOLD will set up to re-test or possibly take out its next major overhead resistance levels at $6.82 to $6.89. Any high-volume move above those levels will then put $7.29 to $8 into focus for shares of FOLD.

Neuralstem (CUR)

This is a biotechnology company, which is engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs. This stock is trading up 10% to $1.20 in recent trading.

Today's Range: $1.09-$1.23

52-Week Range: $0.42-$1.96

Volume: 1.27 million

Three-Month Average Volume: 1.62 million

From a technical perspective, CUR is ripping higher here right off its 50-day moving average of $1.12 with decent volume. This move is quickly pushing CUR within range of triggering a major breakout trade. That trade will hit once CUR mangos to take out some key overhead resistance levels at $1.25 to $1.55 with high volume.

Traders should now look for long-biased trades in CUR as long as it's trending above its 50-day at $1.12, and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.62 million shares. If that breakout triggers soon, then CUR will set up to re-test or possibly take out its next major overhead resistance levels at $1.96 to $2.03.

Celldex Therapeutics (CLDX)

 

This is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases. This stock is trading up 5% to $5.99 in recent trading.

Today's Range: $5.71-$6.00

52-Week Range: $2.37-$6.71

Volume: 570,000

Three-Month Average Volume: 689,355

From a technical perspective, CLDX is trending higher here back above its 50-day moving average of $5.88 with decent volume. This move is quickly pushing CLDX within range of triggering a near-term breakout trade. That trade will hit once CLDX manages to take out some near-term overhead resistance levels at $5.97 to $6.18 with high volume. At last check, CLDX has hit an intraday high of $6 and volume is just a bit below its three-month average action of 689,355 shares.

Traders should now look for long-biased trades in CLDX as long as it's trending above its 50-day at $5.88, and then once it sustains a move or close above those breakout levels with volume that hits near or above 689,355 shares. If that breakout triggers soon, then CLDX will set up to re-test or possibly take out its next major overhead resistance levels at $6.71 to $7. Keep in mind that any move above $6.71 will push CLDX into new 52-week high territory, which is bullish technical price action.

Array BioPharma (ARRY)

This is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. This stock is trading up 6.2% to $3.59 in recent trading.

Today's Range: $3.36-$3.63

52-Week Range: $1.58-$6.17

Volume: 1.27 million

Three-Month Average Volume: 1.08 million

From a technical perspective, ARRY is bouncing higher here right off some near-term support at $3.30 with above-average volume. This stock has been downtrending badly for the last two months, with shares falling from a high of $6.17 to its recent low of $3.25. During that downtrend, shares of ARRY were consistently making lower highs and lower lows, which is bearish technical price action. That said, the stock has now started to rebound and move within range of triggering a near-term breakout trade. That trade will hit once ARRY manages to take out some near-term overhead resistance at $3.59 to $3.63.

Traders should now look for long-biased trades in ARRY as long as it's trending above $3.25, and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.08 million shares. If that breakout trigger soon, then ARRY will set up to re-fill a previous gap down zone that started above $4. If that gap gets filled, then ARRY could easily re-test its 50-day at $4.68 in the near future.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.

RELATED LINKS:

>>5 Dividend Stocks Itching to Pay You More

>>5 Stocks With Large Insider Buying

>>Profit From 5 Stocks Everyone Hates

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.